| Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review A Shakeri, C Adanty Journal of population therapeutics and clinical pharmacology 27 (1), e25-e31, 2020 | 40 | 2020 |
| Biological aging in schizophrenia and psychosis severity: DNA methylation analysis O Dada, C Adanty, N Dai, R Jeremian, S Alli, P Gerretsen, A Graff, ... Psychiatry research 296, 113646, 2021 | 22 | 2021 |
| Sex differences in schizophrenia: a longitudinal methylome analysis C Adanty, J Qian, N Al-Chalabi, AB Fatemi, P Gerretsen, A Graff, ... Journal of Neural Transmission, 1-10, 2022 | 5 | 2022 |
| Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia C Adanty, A Shakeri, J Strauss, A Graff, V De Luca Pharmacogenomics 23 (1), 5-14, 2021 | 3 | 2021 |
| Epigenetics for drug discovery: dissecting the effect of high antipsychotic dosage and D2 blockage on peripheral DNA methylation C Adanty, J Kim, J Strauss, J Qian, G Remington, C Borlido, A Graff, ... Pharmacopsychiatry 55 (04), 211-219, 2022 | 1 | 2022 |
| Revisiting the ethical framework governing water fluoridation and food fortification A Shakeri, C Adanty, H Kugathsan Clinical Ethics 15 (4), 175-180, 2020 | | 2020 |
